{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:39:41Z","timestamp":1770284381403,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["090170"],"award-info":[{"award-number":["090170"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["IP.07.32080.002"],"award-info":[{"award-number":["IP.07.32080.002"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1875-6","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T10:53:10Z","timestamp":1475837590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["QuantiFERON conversion following tuberculin administration is common in HIV infection\u00a0and relates to baseline response"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4278-9316","authenticated-orcid":false,"given":"Hanif","family":"Esmail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Thienemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolu","family":"Oni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene","family":"Goliath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin A.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,7]]},"reference":[{"key":"1875_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.drudis.2011.12.013","volume":"17","author":"H Esmail","year":"2012","unstructured":"Esmail H, Barry 3rd CE, Wilkinson RJ. Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. Drug Discov Today. 2012;17:514\u201321.","journal-title":"Drug Discov Today"},{"key":"1875_CR2","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1084\/jem.20100090","volume":"207","author":"C Geldmacher","year":"2010","unstructured":"Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med. 2010;207:2869\u201381.","journal-title":"J Exp Med"},{"key":"1875_CR3","first-page":"1","volume":"49","author":"ATS\/CDC Statement Committee on Latent Tuberculosis Infection","year":"2000","unstructured":"ATS\/CDC Statement Committee on Latent Tuberculosis Infection. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1\u20135.","journal-title":"MMWR Recomm Rep"},{"key":"1875_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1164\/ajrccm.155.1.9001293","volume":"155","author":"MT Hecker","year":"1997","unstructured":"Hecker MT, Johnson JL, Whalen CC, Nyole S, Mugerwa RD, et al. Two-step tuberculin skin testing in HIV-infected persons in Uganda. Am J Respir Crit Care Med. 1997;155:81\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"1875_CR5","doi-asserted-by":"publisher","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","volume":"7","author":"M Santin","year":"2012","unstructured":"Santin M, Munoz L, Rigau D. Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS ONE. 2012;7:e32482.","journal-title":"PLoS ONE"},{"issue":"Suppl 4","key":"1875_CR6","doi-asserted-by":"publisher","first-page":"S1120","DOI":"10.1093\/infdis\/jir410","volume":"204","author":"JZ Metcalfe","year":"2011","unstructured":"Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis. 2011;204 Suppl 4:S1120\u20139.","journal-title":"J Infect Dis"},{"key":"1875_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","volume":"180","author":"RN Zyl-Smit van","year":"2009","unstructured":"van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, et al. Within-subject variability and boosting of T cell IFN-{gamma} responses following tuberculin skin testing. Am J Respir Crit Care Med. 2009;180:49\u201358.","journal-title":"Am J Respir Crit Care Med."},{"key":"1875_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tube.2011.05.004","volume":"91","author":"I Sauzullo","year":"2011","unstructured":"Sauzullo I, Massetti AP, Mengoni F, Rossi R, Lichtner M, et al. Influence of previous tuberculin skin test on serial IFN-gamma release assays. Tuberculosis. 2011;91:322\u20136.","journal-title":"Tuberculosis"},{"key":"1875_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.5588\/ijtld.10.0339","volume":"15","author":"N Ritz","year":"2011","unstructured":"Ritz N, Yau C, Connell TG, Tebruegge M, Leslie D, et al. Absence of interferon-gamma release assay conversion following tuberculin skin testing. Int J Tuberc Lung Dis. 2011;15:767\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1875_CR10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1378\/chest.07-2193","volume":"133","author":"JC Choi","year":"2008","unstructured":"Choi JC, Shin JW, Kim JY, Park IW, Choi BW, et al. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest. 2008;133:1415\u201320.","journal-title":"Chest"},{"key":"1875_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","volume":"189","author":"SE Dorman","year":"2014","unstructured":"Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014;189:77\u201387.","journal-title":"Am J Respir Crit Care Med"},{"key":"1875_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","volume":"3","author":"BP Ndiaye","year":"2015","unstructured":"Ndiaye BP, Thienemann F, Ota M, Landry BS, Camara M, et al. Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2015;3:190\u2013200.","journal-title":"Lancet Respir Med"},{"key":"1875_CR13","first-page":"406","volume":"14","author":"R Wood","year":"2010","unstructured":"Wood R, Liang H, Wu H, Middelkoop K, Oni T, et al. Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis. 2010;14:406\u201312.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1875_CR14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4269\/ajtmh.2009.80.628","volume":"80","author":"CA Baker","year":"2009","unstructured":"Baker CA, Thomas W, Stauffer WM, Peterson PK, Tsukayama DT. Serial testing of refugees for latent tuberculosis using the QuantiFERON-gold in-tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg. 2009;80:628\u201333.","journal-title":"Am J Trop Med Hyg"},{"key":"1875_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1471-2334-9-182","volume":"9","author":"O Butera","year":"2009","unstructured":"Butera O, Chiacchio T, Carrara S, Casetti R, Vanini V, et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis. 2009;9:182.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1875-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1875-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1875-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T10:51:27Z","timestamp":1692528687000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1875-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1875"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1875-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,7]]},"article-number":"545"}}